vimarsana.com

Page 10 - மூலதனம் மருத்துவ பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Chinese diagnostics firm WuXi Diagnostics raises $150m in Series B round

Chinese diagnostics firm WuXi Diagnostics raises $150m in Series B round WuXi Diagnostics has developed a series of COVID-19 detection products. Source: WuXi Diagnostics February 24, 2021 Chinese integrated diagnostics developer WuXi Diagnostics has raised $150 million in a Series B round of financing to advance its R&D pipeline and open-access innovation enabling platform, as the firm seeks to accelerate its market penetration in the global diagnostics sector. The Series B round was backed by new investors including Thermo Fisher Scientific, the world’s largest maker of scientific instruments; healthcare-focused investment firm Shiyu Capital; ABC International, a wholly-owned subsidiary of Agricultural Bank of China; Sunland Capital, which focuses on early- and growth-stage healthcare investments; and equity investment fund CCBI Tech Venture.

Small lung nodules found in testing not necessarily cancerous, expert says

Small lung nodules found in testing not necessarily cancerous, expert says By WANG XIAODONG | China Daily | Updated: 2021-02-19 09:03 Share CLOSE Strict COVID-19 prevention, control and screening measures in hospitals across China may have helped curb potential deaths caused by lung cancer, a senior expert in lung diseases said. On the other hand, people identified as having small nodules in their lungs during COVID-19 screening should not worry excessively as most such nodules will not develop into cancer, said Zhi Xiuyi, vice-president of the Chinese Association on Tobacco Control. In many places, it has become mandatory for all patients to undergo a computed tomography test on their lungs to rule out novel coronavirus infection before they are hospitalized, said Zhi, also director of Capital Medical University s Lung Cancer Center.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.